The future of Men’s health with PDE5-inhibitors
openaire +3 more sources
An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors. [PDF]
Nemr MTM +4 more
europepmc +1 more source
Rational Design and Optimization of Novel PDE5 Inhibitors for Targeted Colorectal Cancer Therapy: An In Silico Approach. [PDF]
Oladeji SM +4 more
europepmc +1 more source
Synergy between oral PDE5 inhibitors and topically applied nitric oxide microparticles on the erectile response in a rat model of cavernous nerve injury. [PDF]
Tar MT, Draganski A, Davies KP.
europepmc +1 more source
Future perspectives for PDE5 inhibitors bridging the gap between cardiovascular health and psychological status. [PDF]
Sansone A +6 more
europepmc +1 more source
The Comparative Effectiveness of PDE5 Inhibitors and β3 Agonists Versus α-Blockers in Medical Expulsive Therapy for Distal Ureteric Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Ramanah M +5 more
europepmc +1 more source
The safety and efficacy of PDE5-inhibitors-vardenafil on treating diabetes mellitus erectile dysfunction: A protocol for systematic review and meta analysis. [PDF]
He J +10 more
europepmc +1 more source
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents. [PDF]
Pantziarka P +5 more
europepmc +1 more source
Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: Protocol for a systematic review. [PDF]
Li X +6 more
europepmc +1 more source
The Beneficial Effects of Alpha-Blockers, Antimuscarinics, Beta 3-Agonist, and PDE5-Inhibitors for Ureteral Stent-Related Discomfort: A Systematic Review and Meta-Analysis from KSER Update Series. [PDF]
Moon YJ +8 more
europepmc +1 more source

